Newsroom
Newsroom
Press Release
May 23, 2017
Key facts:
Capco to become an independent company.
FIS will receive cash proceeds of $477 million.
CD&R to acquire 60 percent equity interest; FIS to retain 40 percent.
FIS™ (NYSE: FIS), a global leader in financial services technology, and...
Press Release
April 13, 2017
Clayton, Dubilier & Rice and CareCapital Advisors Limited, a specialist investment platform focused on dental and consumer health in Asia and part of Hillhouse Capital Management, today announced an agreement to acquire Carestream’s dental...
Press Release
April 3, 2017
Clayton, Dubilier & Rice announced today the completion of the previously-announced sale of Mauser Group N.V. to Stone Canyon Industries, LLC in an all-cash transaction valued at $2.3 billion.
Mauser, acquired by CD&R funds in 2014, is a...
Press Release
January 6, 2017
Following an active period over the past 24 months, which included nine new platform investments and a series of experienced operating executive additions, Clayton, Dubilier & Rice announced the appointment of four new partners with average...
Press Release
January 4, 2017
Clayton, Dubilier & Rice announced today the completion of the previously announced equity investment by CD&R-managed funds and existing management in Drive DeVilbiss Healthcare. Terms of the transaction were not disclosed.
The new...
Press Release
November 18, 2016
Clayton, Dubilier & Rice (“CD&R”) completed today the previously announced acquisition of BUT, the largest furniture retailer network in France, in a 50:50 partnership with WM Holding, a company related to XXXLutz Group, one of Europe’s...
Press Release
October 4, 2016
Clayton, Dubilier & Rice announced today the formation of agilon health, a new healthcare technology and services platform aiming to accelerate the conversion to value-based healthcare in the United States. The company brings together...
Press Release
August 30, 2016
Clayton, Dubilier & Rice (“CD&R”) announced an agreement today under which CD&R-managed funds will make a significant equity investment alongside existing management in Drive DeVilbiss Healthcare (“Drive”), a global manufacturer of...
Press Release
June 30, 2016
Clayton, Dubilier & Rice announced today that it completed the previously announced acquisition of Kalle GmbH, a leading international industrial manufacturer of artificial casings for the meat processing industry. Terms of the transaction were...
Press Release
June 30, 2016
Clayton, Dubilier & Rice announced today that it completed the previously announced acquisition of High Ridge Brands, the largest North American consolidation platform focused on acquiring orphaned personal care brands. The transaction valued...
- ‹ previous
- 22 of 31
- next ›
The latest insights from
September 15, 2020
Working Capital Review
As early as 2014, global CEOs were already seeing sustainability as a core part of their business... Read More
September 9, 2020
Chris Riback
Joe Coughlin, CEO & Founder of Corporate Risk Solutions
Businesses, of course, face risk every... Read More
June 30, 2020
Working Capital Review
Back in April, we discussed ‘Downsizing the Workforce? It’s a Mistake to Skimp on Cyber Security’ ... Read More
June 2, 2020
Working Capital Review
The risks associated with COVID-19 are more than just to our health. The world economy sustained a... Read More
The latest podcasts from
April 10, 2022
Chris Riback
Working Capital Conversations offers engaging podcasts on business, technology and innovation.Visit... Read More
March 6, 2022
Chris Riback
The Call In podcast helps leaders navigate today’s cancel culture.The bi-weekly show... Read More
February 13, 2022
Chris Riback
The Call In podcast helps leaders navigate today’s cancel culture. The bi-weekly show... Read More
February 6, 2022
Chris Riback
We know the headlines: Inflation is the highest in 40 years, climbing 7 percent last year.... Read More
Press Release
February 17, 2022
Vera Whole Health, Inc. ("Vera") announced today that it has successfully completed its previously announced acquisition of Castlight Health, Inc. ("Castlight") at a price of $2.05 per share, net to the seller, in cash, without interest and subject...
Press Release
February 9, 2022
Clayton, Dubilier & Rice announced the appointment of Andrea Peiro, an experienced technology professional and successful entrepreneur, as an Operating Principal. In his new role, Mr. Peiro will be engaged in evaluating investments and help...
Perspectives
February 7, 2022
The conversation about private equity and environmental, social and corporate governance (ESG) has been largely around reporting guidelines and metrics.
We believe private equity is well-positioned to drive and scale ESG best practices.
The...
Press Release
February 3, 2022
Clayton, Dubilier & Rice today announced Anand Shah, M.D., former U.S. Food and Drug Administration (“FDA”) Deputy Commissioner for Medical and Scientific Affairs, as an Operating Advisor to CD&R funds. Dr. Shah will work with CD&R’s...
Press Release
January 5, 2022
Castlight Health, Inc. (“Castlight”) (NYSE: CSLT), a leading healthcare data and navigation company, and Vera Whole Health, Inc. (“Vera”), a pioneer in advanced primary care, today jointly announced an agreement under which the companies will...
Press Release
December 21, 2021
Clayton, Dubilier & Rice today announced the appointment of Jon Selib, former Senior Vice President of Global Policy & Public Affairs at Pfizer, as Managing Director and Global External Affairs Leader. In his new role, which will take effect...
Press Release
December 17, 2021
Clayton, Dubilier & Rice Fund X today announced the sale of its investment in Belron, a worldwide leader in vehicle glass repair and replacement. The two-part transaction included the sale of approximately 39% of CD&R Fund X’s stake to funds...
Press Release
December 13, 2021
Clayton, Dubilier & Rice announced today that Gordon Riske will be engaged as an Operating Advisor to CD&R funds effective January 1, 2022 after he steps down as Chief Executive Officer of KION GROUP AG, a global provider of materials...
Events
December 7, 2021
CD&R Chairman Don Gogel joined Professor Florin Vasvari, Academic Director of the Institute of Entrepreneurship and Private Capital (IEPC), in a London Business School fireside chat titled, “In conversation with Don Gogel: private capital in...
Events
December 7, 2021
CD&R Chairman Don Gogel discusses trends and opportunities in private capital with Professor Florin Vasvari, Academic Director of the Institute of Entrepreneurship and Private Capital (IEPC) at London Business School.
The video below...
- ‹ previous
- 8 of 31
- next ›
The latest insights from
September 15, 2020
Working Capital Review
As early as 2014, global CEOs were already seeing sustainability as a core part of their business... Read More
September 9, 2020
Chris Riback
Joe Coughlin, CEO & Founder of Corporate Risk Solutions
Businesses, of course, face risk every... Read More
June 30, 2020
Working Capital Review
Back in April, we discussed ‘Downsizing the Workforce? It’s a Mistake to Skimp on Cyber Security’ ... Read More
June 2, 2020
Working Capital Review
The risks associated with COVID-19 are more than just to our health. The world economy sustained a... Read More
The latest podcasts from
April 10, 2022
Chris Riback
Working Capital Conversations offers engaging podcasts on business, technology and innovation.Visit... Read More
March 6, 2022
Chris Riback
The Call In podcast helps leaders navigate today’s cancel culture.The bi-weekly show... Read More
February 13, 2022
Chris Riback
The Call In podcast helps leaders navigate today’s cancel culture. The bi-weekly show... Read More
February 6, 2022
Chris Riback
We know the headlines: Inflation is the highest in 40 years, climbing 7 percent last year.... Read More
Certain persons quoted in certain news items are advisors to CD&R’s funds or executives, employees, directors or persons serving in similar capacities in CD&R’s funds’ portfolio companies, or other persons or organizations who have or may in the future have business or other relationships with CD&R or its funds. Such relationships and any compensation associated with them create a conflict of interest, as the relationship and/or the compensation incentivizes such person to endorse CD&R or its funds.